featured
Sotagliflozin for Type 2 Diabetes and Severe Renal Impairment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes and Severe Renal Impairment
Diabetes Obes Metab 2021 Aug 02;[EPub Ahead of Print], DZI Cherney, E Ferrannini, GE Umpierrez, AL Peters, J Rosenstock, AK Carroll, P Lapuerta, P Banks, R AgarwalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.